No abstract available.
Carcinoma, Basal Cell* ; Nevus*

OBJECTIVE: This study was designed to evaluate whether maternal serum human chorionic gonadotropin(hCG) level measured during second trimester could be used as a predictor of pregnancy-induced hypertension. METHODS: Between March 1996 and November l997, 505 pregnant women undergoing second trimester(14-22 weeks of amenorrhea) triple marker screening for neural tube defect and Down syndrome who delivered at our institution were reviewed. All samples were assayed in the same laboratory and medical records were reviewed about medical and obstetrical history. RESULTS: Maternal serum human chorionic gonadotropin level(multiples of the median, MoM) was significantly higher in the pregnancy-induced hypertension group than in the control group. With the use of 2. l multiples of the median as a cutoff value, the sensitivity of human chorionic gonadotropin as a screening marker for development of pregnancy-induced hypertension was 38.7%, the specificity was 95.9%, positive predictive value was 38.7% and negative predictive value was 95.9%. Conlusion: We suggest that second trimester maternal serum human chorionic gonadotropin levels can be used clinically as an early predictive marker for pregnancy-induced hypertension.
Chorion ; Chorionic Gonadotropin* ; Down Syndrome ; Female ; Humans ; Humans* ; Hypertension* ; Hypertension, Pregnancy-Induced ; Mass Screening ; Medical Records ; Neural Tube Defects ; Pregnancy ; Pregnancy Trimester, Second* ; Pregnancy* ; Pregnant Women ; Sensitivity and Specificity

A polymerase chain reaction (PCR) method for detection of the pathogenic Yersinia pestis from other Yersinia spp. was developed. Five Y. pestis strains, ninety-two other Yersinia species and twenty-four Enterobacteriaceae strains were collected in Korea and from other countries. Oligonucleotide primers were designed from pathogenic gene of antiphagocytic protein capsule gene (fra 1) and plasminogen activator gene (pla). The 428 bp DNA fragment was amplified from five Y. pestis which contained the fra I gene. No product was amplified from other Yersinia species and other strains of the Enterobacteriaceae. The 439 bp DNA fragment was amplified from three K pestis which contained the pla gene. No product was amplified from two Y. pestis, other Yersinia species and other strains of the Enterobacteriaceae. These showed that the designed primers were specific for detection of Y. pestis among other Yersinia species and Enterobacteriaceae strains. Amplification was successful whether the template was derived from purified DNA or from aliquots of boiled bacterial suspension. The detection limits were 100 pg of DNA and 100 colony forming units (CFU) for fra I and 100 pg DNA and 10 CFU for pla, respectively. Our results prove that the PCR method using specific primers for Y. pestis is a rapid and convenient procedure for routine clinical detection and identification of Y. pestis.
DNA ; DNA Primers ; Enterobacteriaceae ; Korea ; Limit of Detection ; Plasminogen Activators ; Polymerase Chain Reaction* ; Stem Cells ; Yersinia pestis* ; Yersinia*

No abstract available.
Cervix Uteri* ; Female ; Magnetic Resonance Imaging*

The corneal curvatures after circumferential scleral resection were increased in the corneal meridian of scleral resection and were decreased in the corneal meridian perpendicular to scleral resection. After meridional scleral resection, the results of corneal curvature changes were opposite to those of circumferential scleral resection. The changes of corneal curvature were decreased with time.

No abstract available.

Although the survival of preterm infants has improved with advances in perinatal care, the occurrence of cerebral palsy has increased further, because infants who would previously have died now survive with their cerebral pathology. In several observational studies, preterm infants whose mothers received magnesium sulfate were reported to have marked reductions in cerebral palsy, as compared with infants of untreated mothers. From meta-analyses of 5 randomized controlled trials of magnesium sulfate therapy given to the mother prior to very preterm birth, magnesium sulfate reduced the rate of cerebral palsy by approximately 30% (relative risk [RR] 0.68, 95% confidence interval [CI] 0.54-0.87) and moderate to severe cerebral palsy (by 40-45%) without increasing the rate of death in 6,145 infants (RR 10.4, 95% CI 0.92-1.17). Given the relative safety of magnesium sulfate for the mother and the lack of evident risk regarding infant mortality, magnesium sulfate should be considered for use as a neuroprotectant in the setting of anticipated preterm birth.
Cerebral Palsy ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Infant, Premature* ; Magnesium Sulfate* ; Magnesium* ; Mothers ; Pathology ; Perinatal Care ; Premature Birth

No abstract availalble.

No abstract available.
Transposases*

PURPOSE: The purpose of this study is to identity the effects of a tailored health promotion program on rural residents' self efficacy, health problems and quality of life. METHOD: Data were collected from May 13th, 2006 to July 29th, 2006. The subjects were selected at Gajo-myeon, Geochang-gun, Gyeonsangbuk-do, Korea. Forty three residents were included in the experimental group and 39 in the control group. The 12-week health promotion program was given to the experimental group. Data were analyzed by descriptive statistics, chi2-test, t-test and ANCOVA test with the SPSS/Win 12.0 program. RESULT: The experimental group showed higher scores of self efficacy and quality of life than the control group, and a lower score of health problem than the control group. CONCLUSION: From the above results, it can be concluded that the tailored health promotion program for rural residents is an effective intervention for improving their self efficacy and quality of life and reducing their health problems. Therefore, it is necessary to spread the tailored health promotion program for residents in other rural areas in Korea.
Gyeongsangbuk-do ; Health Promotion* ; Korea ; Quality of Life* ; Self Efficacy*